Modified linear polyethylenimine-cholesterol conjugates for DNA complexation

被引:67
作者
Furgeson, DY [1 ]
Chan, WS [1 ]
Yockman, JW [1 ]
Kim, SW [1 ]
机构
[1] Univ Utah, Ctr Controlled Chem Delivery, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA
关键词
D O I
10.1021/bc0340565
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Linear polyethylenimine (LPEI) is an effective nonviral gene carrier with transfection levels equal or above branched polyethylenimine (BPEI) and exhibits a lower cytotoxicity profile than BPEI. High molecular weight LPEI M-w 25 k was modified with cholesterol in three different geometries: linear shaped (L), T-shaped (T), and a combined linear/T-shaped (LT) forming the LPEI-cholesterol (LPC) conjugates LPC-L, LPC-T, and LPC-LT, respectively. Physical characterization of LPC/pDNA complexes included particle size, zeta potential, DNase protection, mIL-12 p70 expression, and cytotoxicity. The particle size was further confirmed by atomic force microscopy (AFM). The LPC-T/pDNA complexes were optimal at N/P 10/1 that resulted in a particle size of similar to250 nm, which was confirmed by AFM, and a surface charge of +10 mV. These complexes also effectively protected the pDNA for up to 180 min in the presence of DNase I. B16-F0 cells transfected with LPC-L and LPC-T showed protein expression levels higher than LPEI alone and twice that of BPEI but without any significant loss in cell viability. These results were confirmed with EGFP flow cytometry and transfection of Renca cells. The differences in rates of transfection of the LPC/pDNA complexes is due in part to conformational changes from the point of complex formation to interaction with the plasma membrane. These conformation changes provide protection for unprotonated secondary amines in the LPEI backbone by hydrophobic protection of the cholesterol moiety that we termed "unprotonated reserves". Finally, we show that LPC conjugates exploit receptor-mediated endocytosis via the LDL-R pathway with transgene expression levels decreasing nearly 20% after saturating the LDL-R sites on MCF-7 cells with hLDL-R-Ab.
引用
收藏
页码:840 / 847
页数:8
相关论文
共 30 条
[1]   A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine [J].
Abdallah, B ;
Hassan, A ;
Benoist, C ;
Goula, D ;
Behr, JP ;
Demeneix, BA .
HUMAN GENE THERAPY, 1996, 7 (16) :1947-1954
[2]   Folate-PEG-folate-graft-polyethylenimine-based gene delivery [J].
Benns, JM ;
Maheshwari, A ;
Furgeson, DY ;
Mahato, RI ;
Kim, SW .
JOURNAL OF DRUG TARGETING, 2001, 9 (02) :123-+
[3]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[4]   Overcoming the nuclear barrier:: Cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation [J].
Brunner, S ;
Fürtbauer, E ;
Sauer, T ;
Kursa, M ;
Wagner, E .
MOLECULAR THERAPY, 2002, 5 (01) :80-86
[5]   Side-effects of a systemic injection of linear polyethylenimine-DNA complexes [J].
Chollet, P ;
Favrot, MC ;
Hurbin, A ;
Coll, JL .
JOURNAL OF GENE MEDICINE, 2002, 4 (01) :84-91
[6]   In vivo delivery to tumors of DNA complexed with linear polyethylenimine [J].
Coll, JL ;
Chollet, P ;
Brambilla, E ;
Desplanques, D ;
Behr, JP ;
Favrot, M .
HUMAN GENE THERAPY, 1999, 10 (10) :1659-1666
[7]   A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine:: Effect of molecular weight on transfection efficiency and cytotoxicity [J].
Fischer, D ;
Bieber, T ;
Li, YX ;
Elsässer, HP ;
Kissel, T .
PHARMACEUTICAL RESEARCH, 1999, 16 (08) :1273-1279
[8]   In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. [J].
Fischer, D ;
Li, YX ;
Ahlemeyer, B ;
Krieglstein, J ;
Kissel, T .
BIOMATERIALS, 2003, 24 (07) :1121-1131
[9]   Novel water insoluble lipoparticulates for gene delivery [J].
Furgeson, DY ;
Cohen, RN ;
Mahato, RI ;
Kim, SW .
PHARMACEUTICAL RESEARCH, 2002, 19 (04) :382-390
[10]  
Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO